[Therapy of myasthenia gravis pseudoparalytica].
D000970:Antineoplastic Agents / Q000627:therapeutic use; D002648:Child; D005260:Female; D006801:Humans; D007223:Infant; D008727:Methotrexate / Q000627:therapeutic use; D009157:Myasthenia Gravis / Q000150:complications / Q000188:drug therapy*; D010243:Paralysis / Q000188:drug therapy / Q000209:etiology; D011241:Prednisone / Q000627:therapeutic use; D011729:Pyridostigmine Bromide / Q000627:therapeutic use
D000970:Antineoplastic Agents; D011729:Pyridostigmine Bromide; D011241:Prednisone; D008727:Methotrexate
Ein Beitrag zur Therapie der Myashtenia gravis pseudoparalytica.